Navigation Links
Early Trial of New HIV Drug Shows Promise

Promising results of a new HIV drug has raised the prospect of an effective new treatment against the deadly disease in which the immune system begins to fail. //

The drug 'raltegravir' was given for about 10 years to at least 178 patients with advanced HIV who were not responding to regular anti-retroviral HIV drugs.

The amount of HIV genetic material (RNA) in the blood of the patients was measured after 24 weeks of treatment with their usual HIV drugs plus either raltegravir or a dummy drug.

Patients taking raltegravir had an average of 98 percent drop in their HIV RNA count, compared to just 45 percent drop in the placebo group.

The number of CD4 cells, which give an indication of the immune response, were also significantly boosted in patients taking raltegravir. And the drug was well tolerated by most patients.

"This drug has the potential to become an important component of combination treatment regimens... for patients failing current therapies with multi-drug-resistant virus and limited treatment options," study authors led by Bach-Yen Nguyen of Merck Research Laboratories in Pennsylvania said.

The researchers are hopeful that the new family of drugs will get round the problem of treatment-resistant HIV strains, reported the online edition of BBC News.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and athletics. It’s enough to overwork even the sharpest brain. , Power On, ... peak healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, ...
(Date:2/22/2017)... ... ... The National Academy of Certified Care Managers (NACCM) has ... period. NACCM, a nonprofit organization, has provided the premier certification for Care Managers ... to ensure that newly certified professionals are prepared to work effectively on behalf ...
(Date:2/22/2017)... ... February 22, 2017 , ... A ... smaller and sometimes harder to reach ones, according to the results of a ... Stroke Conference in Houston by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with ...
(Date:2/22/2017)... ... 2017 , ... The first-ever National Heart Valve Disease Awareness ... join together to increase recognition about the risks of heart valve disease (HVD) ... mark a nationwide movement to raise awareness about a disease that has not ...
(Date:2/22/2017)... Pittsburgh, PA (PRWEB) , ... February 22, 2017 , ... ... why some people seem to derive a heart-protective benefit from eating soy foods, while ... , Japanese men who are able to produce equol—a substance made by some ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), today announced its financial ... 31, 2016. ... This news release should be read in conjunction ... analysis for the years ended December 31, 2016 and 2015 ... www.sedar.com and on the Company,s website at ...
(Date:2/22/2017)... -- astic drugs develop from traditional single antineoplastic drug ... functions at multiple links. Research and development of antineoplastic ... Download the full report: https://www.reportbuyer.com/product/4696059/ ... of new tumors in China ... by industrialization and lifestyles changed by factors like urbanization, ...
(Date:2/22/2017)... 2017 Summary Provides understanding ... deals and agreements entered into by the worlds ... http://www.reportlinker.com/p03605673-summary/view-report.html Description The Global Congestive ... and access to partnering deals and agreements entered ... - Trends in partnering deals - ...
Breaking Medicine Technology: